 So Pfizer and Moderna, because they're more nimble and because KP2, which is a child of JN1, is more common right now, as is KP3 and KP1. Those are the fluid variants. They were able to pivot and make something that was more closely resembling what might be circulating in the fall and might be circulating in the winter. But the reason why I said JN1 is because they're all closely related to JN1.